Difficulty: Medium
Average Score: 78%
Practice
Which of the following agents is a full antagonist of opioid receptors?
Correct answer
C
Rationale
In the context of nursing pharmacology, understanding the mechanism of action of different medications is crucial for safe and effective patient care. In this scenario, the correct answer is C) Naloxone, as it is a full antagonist of opioid receptors.
Naloxone is a pure opioid antagonist, meaning it competes with and displaces opioids from the receptors, effectively reversing the effects of opioids. It is commonly used in emergency situations to counteract opioid overdose and restore normal respiratory function by blocking the opioid receptors in the brain.
Meperidine (A) is an opioid analgesic that acts as a partial agonist at opioid receptors and also has serotonergic effects. Buprenorphine (B) is a partial agonist-antagonist at opioid receptors, often used in medication-assisted treatment for opioid addiction. Butorphanol (D) is a mixed agonist-antagonist opioid, with agonist effects at kappa receptors and antagonist effects at mu receptors.
Educationally, this question highlights the importance of differentiating between opioid agonists, partial agonists, antagonists, and mixed agonist-antagonists in pharmacology. Understanding these distinctions is essential for selecting the appropriate medication based on the desired therapeutic effect and potential adverse reactions. It also emphasizes the critical role of naloxone in managing opioid overdoses and underscores its significance in nursing practice.
Naloxone is a pure opioid antagonist, meaning it competes with and displaces opioids from the receptors, effectively reversing the effects of opioids. It is commonly used in emergency situations to counteract opioid overdose and restore normal respiratory function by blocking the opioid receptors in the brain.
Meperidine (A) is an opioid analgesic that acts as a partial agonist at opioid receptors and also has serotonergic effects. Buprenorphine (B) is a partial agonist-antagonist at opioid receptors, often used in medication-assisted treatment for opioid addiction. Butorphanol (D) is a mixed agonist-antagonist opioid, with agonist effects at kappa receptors and antagonist effects at mu receptors.
Educationally, this question highlights the importance of differentiating between opioid agonists, partial agonists, antagonists, and mixed agonist-antagonists in pharmacology. Understanding these distinctions is essential for selecting the appropriate medication based on the desired therapeutic effect and potential adverse reactions. It also emphasizes the critical role of naloxone in managing opioid overdoses and underscores its significance in nursing practice.